Document Detail

L-threonine as a symptomatic treatment for amyotrophic lateral sclerosis (ALS).
MedLine Citation:
PMID:  1905383     Owner:  NLM     Status:  MEDLINE    
ALS is a fatal, neurological disease of unknown origin with no present cure. A recent pilot study has shown that L-threonine, an essential amino acid, may be effective in the symptomatic treatment of ALS. Relevant information discussing the potential role of L-threonine in the treatment of ALS is presented.
J B Roufs
Related Documents :
20019093 - Recent progress in deciphering the biosynthesis of aspartate-derived amino acids in pla...
22248073 - Saturated long-chain fatty acids activate inflammatory signaling in astrocytes.
18961043 - The absorption of carbon dioxide in solutions of monoethanolamine.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Medical hypotheses     Volume:  34     ISSN:  0306-9877     ISO Abbreviation:  Med. Hypotheses     Publication Date:  1991 Jan 
Date Detail:
Created Date:  1991-07-29     Completed Date:  1991-07-29     Revised Date:  2008-08-15    
Medline Journal Info:
Nlm Unique ID:  7505668     Medline TA:  Med Hypotheses     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  20-3     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amyotrophic Lateral Sclerosis / drug therapy*,  physiopathology
Central Nervous System / metabolism
Glycine / metabolism
Models, Biological
Threonine / therapeutic use*
Reg. No./Substance:
56-40-6/Glycine; 72-19-5/Threonine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  DNA damage induced by 7,12-dimethylbenz[a]anthracene in the liver and the mammary gland of rats expo...
Next Document:  Measuring and modifying hospital drug use.